BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 38539461)

  • 1. Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.
    Pan Y; Cengiz R; Kluiver J; Diepstra A; Van den Berg A
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated miRNAs Contribute to Silencing of B-Cell Specific Transcription Factors and Activation of NF-κB in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Ustaszewski A; Bein J; Skalski M; Dzikiewicz-Krawczyk A; Rozwadowska N; Hansmann ML; Hartmann S; Giefing M
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
    Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
    Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA signature in classical Hodgkin lymphoma.
    Paczkowska J; Giefing M
    J Appl Genet; 2021 May; 62(2):281-288. PubMed ID: 33544339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables.
    Paydas S; Acikalin A; Ergin M; Celik H; Yavuz B; Tanriverdi K
    Med Oncol; 2016 Apr; 33(4):34. PubMed ID: 26951445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.
    Yuan Y; Kluiver J; Koerts J; de Jong D; Rutgers B; Abdul Razak FR; Terpstra M; Plaat BE; Nolte IM; Diepstra A; Visser L; Kok K; van den Berg A
    Am J Pathol; 2017 Jun; 187(6):1343-1355. PubMed ID: 28432871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
    Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
    Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex Epigenetic Regulation of Chemotherapy Resistance and Biohlogy in Esophageal Squamous Cell Carcinoma via MicroRNAs.
    Lindner K; Eichelmann AK; Matuszcak C; Hussey DJ; Haier J; Hummel R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29414899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells.
    Zhou F; Wang W; Xing Y; Wang T; Xu X; Wang J
    Biochim Biophys Acta; 2014; 1839(4):344-54. PubMed ID: 24418602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
    Sánchez-Espiridión B; Martín-Moreno AM; Montalbán C; Figueroa V; Vega F; Younes A; Medeiros LJ; Alvés FJ; Canales M; Estévez M; Menarguez J; Sabín P; Ruiz-Marcellán MC; Lopez A; Sánchez-Godoy P; Burgos F; Santonja C; López JL; Piris MA; Garcia JF
    Br J Haematol; 2013 Aug; 162(3):336-47. PubMed ID: 23725219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin Lymphoma.
    Drees EEE; Roemer MGM; Groenewegen NJ; Perez-Boza J; van Eijndhoven MAJ; Prins LI; Verkuijlen SAWM; Tran XM; Driessen J; Zwezerijnen GJC; Stathi P; Mol K; Karregat JJJP; Kalantidou A; Vallés-Martí A; Molenaar TJ; Aparicio-Puerta E; van Dijk E; Ylstra B; Groothuis-Oudshoorn CGM; Hackenberg M; de Jong D; Zijlstra JM; Pegtel DM
    J Extracell Vesicles; 2021 Jul; 10(9):e12121. PubMed ID: 34295456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
    Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
    Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNAs from Inflamed Gingiva Link Gene Signaling to Increased MET Expression.
    Zheng L; Chopra A; Weiner J; Beule D; Dommisch H; Schaefer AS
    J Dent Res; 2023 Dec; 102(13):1488-1497. PubMed ID: 37822091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
    Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
    Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma.
    Jones K; Nourse JP; Keane C; Bhatnagar A; Gandhi MK
    Clin Cancer Res; 2014 Jan; 20(1):253-64. PubMed ID: 24222179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.